|
|
Volumn 20, Issue 1, 2002, Pages 15-16
|
|
Designing drugs against heterogeneous targets
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
INDINAVIR;
NELFINAVIR;
PROTEINASE INHIBITOR;
RITONAVIR;
SAQUINAVIR;
ANTIBIOTIC RESISTANCE;
DRUG BINDING SITE;
DRUG DESIGN;
DRUG EFFICACY;
DRUG PROTEIN BINDING;
ENTHALPY;
ENTROPY;
GENE MAPPING;
GENE MUTATION;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYDROPHOBICITY;
NOTE;
PRIORITY JOURNAL;
REACTION ANALYSIS;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
ANTIVIRAL AGENTS;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
LIGANDS;
MODELS, MOLECULAR;
MUTATION;
PROTEASE INHIBITORS;
THERMODYNAMICS;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
|
EID: 0036137494
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0102-15 Document Type: Note |
|
Times cited : (42)
|
|
References (10)
|
